Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines.

R J Wool-Lewis1 P Bates
Affiliations 1 institutions
  1. Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia 19104-6076, USA.

Abstract

Studies analyzing Ebola virus replication have been severely hampered by the extreme pathogenicity of this virus. To permit analysis of the host range and function of the Ebola virus glycoprotein (Ebo-GP), we have developed a system for pseudotyping these glycoproteins into murine leukemia virus (MLV). This pseudotyped virus, MLV(Ebola), can be readily concentrated to titers which exceed 5 x 10(6) infectious units/ml and is effectively neutralized by antibodies specific for Ebo-GP. Analysis of MLV(Ebola) infection revealed that the host range conferred by Ebo-GP is very broad, extending to cells of a variety of species. Notably, all lymphoid cell lines tested were completely resistant to infection; we speculate that this is due to the absence of a cellular receptor for Ebo-GP on B and T cells. The generation of high-titer MLV(Ebola) pseudotypes will be useful for the analysis of immune responses to Ebola virus infection, development of neutralizing antibodies, analysis of glycoprotein function, and isolation of the cellular receptor(s) for the Ebola virus.

Genetic Vectors 2 Ammonium Chloride 1 Animals 1948 Cattle 126 Cell Line 158 Cell Line, Transformed 0 Chlorocebus aethiops 70 Chloroquine 0 COS Cells 4 Cricetinae 41 Dogs 176 Ebolavirus 31 Gene Expression 10 HeLa Cells 13 Humans 1440 Leukemia Virus, Murine 2 Membrane Glycoproteins 26 Neutralization Tests 31 Receptors, Virus 204 Recombinant Fusion Proteins 5 Swine 258 Vero Cells 55 Viral Matrix Proteins 7 transmembrane glycoprotein, Ebola virus 0

Evidence records

0 total

No structured evidence records are linked to this article.